{
  "drug_name": "Procedures_in_patients_with_coagulopathies",
  "url": "https://wikem.org/wiki/Procedures_in_patients_with_coagulopathies",
  "scraped_at": "2026-01-10T08:00:37.600116",
  "sections": {
    "Background": {
      "text": "Evidence is mostly retrospective studies or case reports\nClinical practice should account for totality of circumstances, including operator experience",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Central_Line": {
      "text": "",
      "subsections": {
        "Central_line_if_coagulopathic": {
          "text": "Preferentially use a compressible site such as the\nfemoral\nlocation (avoid the\nIJ\nand\nsubclavian\nif possible, though IJ preferred over subclavian)\nNo benefit to giving\nFFP\nunless artery is punctured\n[1]\nHowever, consider giving\nFFP\nif patient has\nhemophilia\n[2]",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "femoral",
          "url": "https://wikem.org/wiki/Central_line:_femoral"
        },
        {
          "text": "IJ",
          "url": "https://wikem.org/wiki/Central_line:_internal_jugular"
        },
        {
          "text": "subclavian",
          "url": "https://wikem.org/wiki/Central_line:_subclavian"
        },
        {
          "text": "FFP",
          "url": "https://wikem.org/wiki/FFP"
        },
        {
          "text": "FFP",
          "url": "https://wikem.org/wiki/FFP"
        },
        {
          "text": "hemophilia",
          "url": "https://wikem.org/wiki/Hemophilia"
        }
      ]
    },
    "Central_line_if_coagulopathic": {
      "text": "Preferentially use a compressible site such as the\nfemoral\nlocation (avoid the\nIJ\nand\nsubclavian\nif possible, though IJ preferred over subclavian)\nNo benefit to giving\nFFP\nunless artery is punctured\n[1]\nHowever, consider giving\nFFP\nif patient has\nhemophilia\n[2]",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "femoral",
          "url": "https://wikem.org/wiki/Central_line:_femoral"
        },
        {
          "text": "IJ",
          "url": "https://wikem.org/wiki/Central_line:_internal_jugular"
        },
        {
          "text": "subclavian",
          "url": "https://wikem.org/wiki/Central_line:_subclavian"
        },
        {
          "text": "FFP",
          "url": "https://wikem.org/wiki/FFP"
        },
        {
          "text": "FFP",
          "url": "https://wikem.org/wiki/FFP"
        },
        {
          "text": "hemophilia",
          "url": "https://wikem.org/wiki/Hemophilia"
        }
      ]
    },
    "Lumbar_Puncture": {
      "text": "",
      "subsections": {
        "Lumbar_puncture_if_coagulopathic": {
          "text": "Tranfuse if platelets <25,000\n[3]\n[4]\nINR >1.5\nHemophilia, von Willebrand disease, other coagulopathies\nIf hemophiliac, replace factor before LP",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Lumbar_puncture_if_coagulopathic": {
      "text": "Tranfuse if platelets <25,000\n[3]\n[4]\nINR >1.5\nHemophilia, von Willebrand disease, other coagulopathies\nIf hemophiliac, replace factor before LP",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Paracentesis": {
      "text": "",
      "subsections": {
        "Paracentesis_if_coagulopathic": {
          "text": "Coagulation studies are NOT required before performance of the procedure\n[5]\nIncidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)\n[6]\nNo data supports cutoff values beyond which paracentesis should be avoided/prophylactically transfused\nRoutine use of\nFFP\nand\nplatelets\nis not recommended\nProcedure is contraindicated if the patient is actively bleeding or in\nDIC",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "FFP",
          "url": "https://wikem.org/wiki/FFP"
        },
        {
          "text": "platelets",
          "url": "https://wikem.org/wiki/Platelets"
        },
        {
          "text": "DIC",
          "url": "https://wikem.org/wiki/DIC"
        }
      ]
    },
    "Paracentesis_if_coagulopathic": {
      "text": "Coagulation studies are NOT required before performance of the procedure\n[5]\nIncidence of clinically significant bleeding complications is low even if in liver failure with an elevated INR (< 0.2%)\n[6]\nNo data supports cutoff values beyond which paracentesis should be avoided/prophylactically transfused\nRoutine use of\nFFP\nand\nplatelets\nis not recommended\nProcedure is contraindicated if the patient is actively bleeding or in\nDIC",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "FFP",
          "url": "https://wikem.org/wiki/FFP"
        },
        {
          "text": "platelets",
          "url": "https://wikem.org/wiki/Platelets"
        },
        {
          "text": "DIC",
          "url": "https://wikem.org/wiki/DIC"
        }
      ]
    },
    "Thoracentesis": {
      "text": "",
      "subsections": {
        "Thoracentesis_if_coagulopathic": {
          "text": "Platelets <50K\n[7]\nINR >2x normal\n[7]\nMechanical ventilation",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Thoracentesis_if_coagulopathic": {
      "text": "Platelets <50K\n[7]\nINR >2x normal\n[7]\nMechanical ventilation",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Specific_Populations": {
      "text": "",
      "subsections": {
        "Cirrhosis": {
          "text": "INR is a poor marker of coagulation in\ncirrhosis\nRisk of post-procedure bleeding for minimally invasive procedures ~20% in cirrhotics\nEach 100 cc infusion of plasma increases portal venous pressure by 1 mmHg (normal pressure 5-10 mmHg)\nCorrection of elevated INR in\ncirrhosis\nleads to unnecessary volume expansion\nPT/INR only measures the procoagulant pathway and does not detect anticoagulant pathway (protein C and S, antithrombin)\nThus, cirrhotic patients may be hypercoagulable despite high INR due to natural anticoagulant deficiencies\n[9]\nDo not use PT/INR to risk stratify liver disease patients\nRather use target platelet count with goal > 50,000 uL and fibrinogen level > 120 mg/dL",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        },
        {
          "text": "cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        }
      ]
    },
    "Cirrhosis": {
      "text": "INR is a poor marker of coagulation in\ncirrhosis\nRisk of post-procedure bleeding for minimally invasive procedures ~20% in cirrhotics\nEach 100 cc infusion of plasma increases portal venous pressure by 1 mmHg (normal pressure 5-10 mmHg)\nCorrection of elevated INR in\ncirrhosis\nleads to unnecessary volume expansion\nPT/INR only measures the procoagulant pathway and does not detect anticoagulant pathway (protein C and S, antithrombin)\nThus, cirrhotic patients may be hypercoagulable despite high INR due to natural anticoagulant deficiencies\n[9]\nDo not use PT/INR to risk stratify liver disease patients\nRather use target platelet count with goal > 50,000 uL and fibrinogen level > 120 mg/dL",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        },
        {
          "text": "cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        }
      ]
    },
    "See_Also": {
      "text": "Coagulopathy (Main)",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Coagulopathy (Main)",
          "url": "https://wikem.org/wiki/Coagulopathy_(Main)"
        }
      ]
    },
    "External_Links": {
      "text": "http://www.sirweb.org/clinical/cpg/4E8CAd01.pdf",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}